| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8708923 | Sleep Medicine | 2018 | 21 Pages |
Abstract
These data suggest persons entering insomnia hypnotic clinical trials are a highly selected sample that is unlikely to be representative of the broad insomnia population or the population of potential medication users.
Keywords
OCDDSM5NPSGZopicloneFDAIVRSNIDAbenzodiazepine receptor agonistMSLTaHIIRBSCIDMultiple sleep latency testSubstance use disorderFood & Drug AdministrationelectrocardiogramECGUnited StatesSleep efficiencyover-the-counterChronic obstructive pulmonary diseaseCOPDSUDCNSZolpidemcentral nervous systemApnea hypopnea indexThe Netherlandsinstitutional review boardClinical trial
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
T. Roehrs, J.C. Verster, G. Koshorek, D. Withrow, T. Roth,